Epigenomic profiling is transforming how researchers study gene regulation by revealing the DNA, chromatin, and RNA-based mechanisms that control cellular identity and response to environmental cues. While genomics shows what is possible and transcriptomics shows what is happening, epigenomics explains how regulatory states are established and maintained across tissues and disease contexts.
This article from Biocompare reviews major epigenomic methods, including DNA methylation profiling, histone modification analysis, and chromatin accessibility assays. Each approach has tradeoffs in sample input, resolution, noise, and workflow complexity, so method choice depends on the biological question.
Recent advances are improving performance through enzymatic methylation sequencing, targeted nuclease-based methods, and streamlined kits that reduce sample loss and variability. These innovations are especially valuable for rare cells and limited clinical specimens.
The rise of single-cell epigenomics, including large-scale tissue atlases that map cell type-specific regulatory programs and aging-related chromatin changes, is also covered in this article.
Together, these developments are expanding the use of epigenomic profiling in basic research, disease classification, therapeutic response prediction, and precision medicine.